A disruptive solution for treating chronic heart failure

GizaVC invests in the vision of most innovative entrepreneurs.


Circulite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally invasive micro-pumps for long term partial circulatory support. By enabling a proactive and lower-risk treatment approach, supplementing a patient's pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients.

circulite c



Paul J. Southworth


CEO: Paul J. Southworth           

Giza's Team Member

Elka Nir



Fields of invesment:icon life Healthcare

Contact info: Website